在IRF8突变B细胞淋巴瘤中,通过CD74依赖的抗原处理和呈现在MHCII复合体中的放松调节来逃避免疫力
Zhijun Qiu1, Jihane Khalife1, Purushoth Ethiraj1
1Division of Hematology and Medical Oncology, Department of Medicine, Mays Cancer Center, University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA.
Science advances
|July 12, 2024
概括
淋巴瘤中的干扰素调节因子8 (IRF8) 突变会损害抗原呈现,导致免疫逃避. 这项研究揭示了IRF8变异如何促进瘤生长并改变瘤微环境,有助于扩散大B细胞淋巴瘤 (DLBCL) 的进展.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 干扰素调节因子8 (IRF8) 突变在淋巴发育中的作用尚不清楚.
- 了解IRF8的功能对于B细胞淋巴瘤研究至关重要.
研究的目的:
- 调查IRF8突变对淋巴发育产生贡献的机制.
- 阐明IRF8变异对B细胞淋巴瘤抗原呈现和瘤微环境的影响.
主要方法:
- 在小鼠B细胞淋巴瘤中模拟IRF8变异.
- 分析抗原呈现调节者的表达,包括CD74和HLA-DM.
- 评估瘤微环境中的T细胞激活 (CD4,CD8) 和免疫细胞种群.
- 利用在人类扩散型大B细胞淋巴瘤 (DLBCL) 样本上的大量RNA测序和解卷分析.
主要成果:
- IRF8突变导致CD4+T细胞激活受损,并降低CD74和HLA-DM的调节,这是MHCII类抗原处理的关键调节者.
- 突变IRF8表现出对基因促进体的结合减少.
- 小鼠的IRF8突变淋巴瘤显示瘤负担增加和显著的免疫细胞重塑,包括CD4 +,CD8 +和NK细胞枯竭,以及调节性T细胞和T毛囊辅助细胞的增加.
- 对人类DLBCL样本的分析揭示了类似的免疫微环境变化.
结论:
- 通过破坏抗原呈现和促进免疫逃逸,IRF8突变有助于DLBCL的致病性.
- 这些发现强调了IRF8作为DLBCL的潜在治疗点.
- 这项研究提供了关于在淋巴瘤发育过程中遗传突变和免疫逃避之间的复杂相互作用的见解.
相关概念视频
Antigen Processing Pathways
985
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
985
T Cell Activation and Clonal Selection
697
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
697
B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
Antigens Involved in Adaptive Immunity
482
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
482


